These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38646535)
21. Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin. Gao X; Ma Y; Wang Z; Bai J; Jia S; Feng B; Jiang Y; Cui W; Tang L; Li Y; Wang L; Xu Y Virulence; 2019 Dec; 10(1):166-179. PubMed ID: 30806148 [TBL] [Abstract][Full Text] [Related]
22. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C. Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945 [TBL] [Abstract][Full Text] [Related]
23. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture. Knight PA; Queminet J; Blanchard JH; Tilleray JH Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500 [TBL] [Abstract][Full Text] [Related]
29. The titration of clostridial toxoids and antisera in cell culture. Knight PA; Burnett C; Whitaker AM; Queminet J Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845 [TBL] [Abstract][Full Text] [Related]
30. Oral vaccination of broiler chickens against necrotic enteritis using a non-virulent NetB positive strain of Clostridium perfringens type A. Mishra N; Smyth JA Vaccine; 2017 Dec; 35(49 Pt B):6858-6865. PubMed ID: 29102330 [TBL] [Abstract][Full Text] [Related]
31. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis. Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Van Immerseel F Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219 [TBL] [Abstract][Full Text] [Related]
32. Expression of the alpha toxin of Clostridium perfringens in Lactobacillus casei genome and evaluation of its immune effects in mice. Song B; Cui H; Ju L; Song L; Tang L; Li Y Microb Pathog; 2018 May; 118():1-8. PubMed ID: 29524545 [TBL] [Abstract][Full Text] [Related]
33. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413 [TBL] [Abstract][Full Text] [Related]
34. [Occurrence and control of the Clostridium perfringens type A associated diarrhea of the suckling pigs with special consideration of the immunoprophylaxis]. Springer S; Finzel J; Florian V; Schoepe H; Woitow G; Selbitz HJ Tierarztl Prax Ausg G Grosstiere Nutztiere; 2012; 40(6):375-82. PubMed ID: 23242147 [TBL] [Abstract][Full Text] [Related]
35. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis. Wang Y; Miao Y; Hu LP; Kai W; Zhu R Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084 [TBL] [Abstract][Full Text] [Related]
36. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin. El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625 [TBL] [Abstract][Full Text] [Related]
37. Total combining power: Technique for the evaluation of the quality control process of clostridiosis vaccines. Brandi IV; Santos EM; Carvalho BM; Durães CA; Farias PK; Sari RS; Cangussu AS; Pessoa A J Microbiol Methods; 2016 Nov; 130():164-168. PubMed ID: 27569385 [TBL] [Abstract][Full Text] [Related]
38. Vero cell assay for rapid detection of Clostridium perfringens enterotoxin. Mahony DE; Gilliatt E; Dawson S; Stockdale E; Lee SH Appl Environ Microbiol; 1989 Sep; 55(9):2141-3. PubMed ID: 2552918 [TBL] [Abstract][Full Text] [Related]
39. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein. Uppalapati SR; Kingston JJ; Murali HS; Batra HV Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467 [TBL] [Abstract][Full Text] [Related]
40. Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines. Viana Brandi I; Domenici Mozzer O; Jorge EV; Vieira Passos FJ; Lopes Passos FM; Cangussu AS; Macedo Sobrinho E Bioprocess Biosyst Eng; 2014 Sep; 37(9):1737-42. PubMed ID: 24573216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]